[ad_1] Think a friend or colleague should be getting this newsletter? Share this link with them…
Tag: Biotech and Pharmaceuticals
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
[ad_1] Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug…
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
[ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at…
Healthy Returns: What we know about the next round of Covid vaccines
[ad_1] Pharmacist Aaron Sun prepares Pfizer’s new Covid vaccine Comirnaty at CVS Pharmacy in Eagle Rock,…
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
[ad_1] Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was…
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
[ad_1] A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters…
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
[ad_1] Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to…
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
[ad_1] The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and…
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
[ad_1] CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer…
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
Two CVS retail stores in Rhode Island join new national pharmacy union
[ad_1] The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store…
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class…
A corner of the cancer therapy market is heating up—Here are the names investors need to know
[ad_1] There’s been a lot of attention lately on a corner of the oncology market called…